Prostate Cancer Webinars

Combating T-cell Dysfunction in Cutaneous Squamous Cell Carcinoma: Integrating Checkpoint Inhibitors into Clinical Practice and Managing Adverse Events

Combating T-cell Dysfunction in Cutaneous Squamous Cell Carcinoma: Integrating Checkpoint Inhibitors into Clinical Practice and Managing Adverse Events

This enduring activity is focused on the management of patients with advanced or metastatic cutaneous squamous cell carcinoma.

Release Date: January 31, 2020
Expiration Date: January 31, 2021

Learn More & View Event »

A Virtual Reality View New Approaches to the Diagnosis and Treatment of Pediatric and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

A Virtual Reality View New Approaches to the Diagnosis and Treatment of Pediatric and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

While guidelines regarding the management of AD in children have been published, variability persists in practice. Treatment inconsistencies and the chronic and relapsing nature of AD can lead to frustration for patients, family, and caregivers when managing AD. This program will focus on providing AD caregivers an update on recent pathophysiological findings that drive new therapeutic targets; reviewing severity and diagnosis of AD; and discussing the clinical profiles of existing and emerging agents, with focus on treatment individualization.

Release Date: June 11, 2020
Expiration Date: June 11, 2021

Learn More & View Event »

A Virtual Reality View New Approaches to the Diagnosis and Treatment of Pediatric and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

A Virtual Reality View New Approaches to the Diagnosis and Treatment of Pediatric and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis

While guidelines regarding the management of AD in children have been published, variability persists in practice. Treatment inconsistencies and the chronic and relapsing nature of AD can lead to frustration for patients, family, and caregivers when managing AD. This program will focus on providing AD caregivers an update on recent pathophysiological findings that drive new therapeutic targets; reviewing severity and diagnosis of AD; and discussing the clinical profiles of existing and emerging agents, with focus on treatment individualization.

Release Date: June 11, 2020
Expiration Date: June 11, 2021

Learn More & View Event »

A Virtual Reality Tour – The Role of Risk Evaluation in Minimizing Recurrence and Metastasis in Patients with cSCC Undergoing Surgical Intervention

A Virtual Reality Tour – The Role of Risk Evaluation in Minimizing Recurrence and Metastasis in Patients with cSCC Undergoing Surgical Intervention

This enduring activity is focused on the management of patients with advanced or metastatic cutaneous squamous cell carcinoma.

Release Date: June 12, 2020
Expiration Date: June 12, 2021

Learn More & View Event »

Improving the Ability to Diagnose and Treat Atopic Dermatitis in Clinical Practice A part of the THRIVE – Atopic Dermatitis Initiative

This “situation room” activity allows learners to practice making clinical decisions in the management of patients with moderate-to-severe atopic dermatitis. Learners will view simulated 3D interactions between patients and their physicians and use information from the patients’ electronic charts to decide the next best course of action. Topics covered in this activity include assessment of disease severity and quality of life, intensification of treatment, and recognizing adverse events.

Release Date: November 4, 2020
Expiration Date: November 4, 2021

Learn More & View Event »

A Whiteboard View of the New Era in Alopecia Areata: The Role of JAK Inhibitors

This case-based activity targets healthcare gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health-related quality of life through burden of disease and associated comorbidities. This content was co-created by Dr. Brett King (New Haven, CT) and Dr. Rodney Sinclair (Melbourne, Australia).

  • By addressing these gaps, you can assess whether your approach to AA management through utilization of immune-related targeted treatment approaches and comorbidity assessment – could be modified to help close these gaps.
  • Expert discussion will guide you in analyzing and identifying appropriate candidates for immune-targeted treatment of alopecia with JAK inhibitors, as well as assessment and management strategies for associated comorbidities.
  • You will also be immersed in dynamic animations utilizing a whiteboard platform to memorably highlight key points related to immune pathways in the development of alopecia areata and patient counseling techniques for tailored disease and comorbidity management.

Release Date: February 25, 2021
Expiration Date: February 25, 2022

Learn More & View Event »

A Whiteboard View of the New Era in Alopecia Areata: The Role of JAK Inhibitors

This enduring, case-based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health-related quality of life through burden of disease and associated comorbidities.

  • By addressing these gaps, you can assess whether your approach to AA management using immune-related targeted treatment approaches and comorbidity assessment could be modified to help close these gaps.
  • Expert discussion will guide you in analyzing and identifying appropriate candidates for immune-targeted treatment of alopecia with JAK inhibitors, as well as assessment and management strategies for associated comorbidities.
  • You will also be immersed in dynamic animations using a whiteboard platform to memorably highlight key points related to immune pathways in the development of alopecia areata and patient counseling techniques for tailored disease and comorbidity management.

Release Date: June 16, 2021
Expiration Date: June 16, 2022

Learn More & View Event »

Moderate-to-Severe Atopic Dermatitis: Improving Patient Adherence to Therapy Among Veterans During the COVID-19 Pandemic

This enduring education is designed to help dermatologists, allergists, immunologists, primary care physicians, and other health care professionals in the Department of Veterans Affairs to identify the signs and symptoms of atopic dermatitis in adult patients, assess disease severity, incorporate updated guidance on the use of systemic therapy for atopic dermatitis during the COVID-19 pandemic into clinical practice, and utilize shared decision making to help individualize care.

Release Date: August 26, 2021
Expiration Date: August 26, 2022

Learn More & View Event »
Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.